Invivyd Inc (IVVD) Stock Observes -59.68% 200-Day Moving Average

The stock of Invivyd Inc (IVVD) has seen a 19.99% increase in the past week, with a 5.70% gain in the past month, and a -37.04% decrease in the past quarter. The volatility ratio for the week is 11.53%, and the volatility levels for the past 30 days are at 13.54% for IVVD. The simple moving average for the past 20 days is 9.61% for IVVD’s stock, with a -59.68% simple moving average for the past 200 days.

Is It Worth Investing in Invivyd Inc (NASDAQ: IVVD) Right Now?

The 36-month beta value for IVVD is also noteworthy at 0.58. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for IVVD is 72.60M, and at present, short sellers hold a 10.87% of that float. The average trading volume of IVVD on September 12, 2024 was 611.30K shares.

IVVD) stock’s latest price update

The stock price of Invivyd Inc (NASDAQ: IVVD) has jumped by 13.31 compared to previous close of 0.90. Despite this, the company has seen a gain of 19.99% in its stock price over the last five trading days. globenewswire.com reported 2024-09-05 that WALTHAM, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it will present at the following investor conferences:

Analysts’ Opinion of IVVD

Many brokerage firms have already submitted their reports for IVVD stocks, with Guggenheim repeating the rating for IVVD by listing it as a “Buy.” The predicted price for IVVD in the upcoming period, according to Guggenheim is $9 based on the research report published on April 05, 2024 of the current year 2024.

Morgan Stanley, on the other hand, stated in their research note that they expect to see IVVD reach a price target of $10, previously predicting the price at $4. The rating they have provided for IVVD stocks is “Overweight” according to the report published on March 26th, 2024.

Morgan Stanley gave a rating of “Equal-Weight” to IVVD, setting the target price at $4 in the report published on December 19th of the previous year.

IVVD Trading at -5.01% from the 50-Day Moving Average

After a stumble in the market that brought IVVD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -80.37% of loss for the given period.

Volatility was left at 13.54%, however, over the last 30 days, the volatility rate increased by 11.53%, as shares sank -3.77% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -15.00% lower at present.

During the last 5 trading sessions, IVVD rose by +19.99%, which changed the moving average for the period of 200-days by -32.00% in comparison to the 20-day moving average, which settled at $0.9286. In addition, Invivyd Inc saw -74.11% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at IVVD starting from MCGUIRE TERRANCE, who sale 112,381 shares at the price of $1.66 back on May 29 ’24. After this action, MCGUIRE TERRANCE now owns 4,688,079 shares of Invivyd Inc, valued at $186,575 using the latest closing price.

Adimab, LLC, the 10% Owner of Invivyd Inc, sale 5,000,000 shares at $3.95 during a trade that took place back on Jan 19 ’24, which means that Adimab, LLC is holding 21,687,906 shares at $19,750,000 based on the most recent closing price.

Stock Fundamentals for IVVD

Current profitability levels for the company are sitting at:

  • -40.8 for the present operating margin
  • 0.59 for the gross margin

The net margin for Invivyd Inc stands at -38.55. The total capital return value is set at -1.53. Equity return is now at value -96.56, with -82.73 for asset returns.

Based on Invivyd Inc (IVVD), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -273.72. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is -57.53.

Currently, EBITDA for the company is -205.75 million with net debt to EBITDA at 0.69. When we switch over and look at the enterprise to sales, we see a ratio of -4.8. The receivables turnover for the company is 1.5for trailing twelve months and the total asset turnover is 0.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.71.

Conclusion

In summary, Invivyd Inc (IVVD) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts